A61K 31/593
9,10-secocholestane derivatives
Official title: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
A61K31/593 (9,10-secocholestane derivatives) appears on 849 US grants and 1,808 published applications in this corpus.
Search patents in A61K- Granted patents
- 849
- Published applications
- 1,808
- Assignees
- 805
- Inventors
- 2,692
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 9 | 0 |
| 1998 | 18 | 0 |
| 1999 | 12 | 0 |
| 2000 | 11 | 0 |
| 2001 | 11 | 4 |
| 2002 | 13 | 16 |
| 2003 | 8 | 26 |
| 2004 | 4 | 26 |
| 2005 | 12 | 39 |
| 2006 | 13 | 27 |
| 2007 | 6 | 21 |
| 2008 | 5 | 28 |
| 2009 | 5 | 29 |
| 2010 | 6 | 53 |
| 2011 | 7 | 52 |
| 2012 | 16 | 38 |
| 2013 | 22 | 67 |
| 2014 | 30 | 74 |
| 2015 | 36 | 84 |
| 2016 | 42 | 120 |
| 2017 | 56 | 105 |
| 2018 | 67 | 109 |
| 2019 | 73 | 94 |
| 2020 | 55 | 93 |
| 2021 | 55 | 125 |
| 2022 | 56 | 161 |
| 2023 | 46 | 136 |
| 2024 | 62 | 103 |
| 2025 | 45 | 92 |
| 2026 | 27 | 86 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Fibrous composite material8 Sep 2026US 12,728,101 B2The Electrospinning Company Ltd
- Method of increasing the population of Dialister spp. in the gut microbiome8 Sep 2026US 12,728,109 B2Dsm IP Assets B.V.
- Methods and compositions for reducing parathyroid levels18 Aug 2026US 12,708,629 B2Eirgen Pharma Ltd.
- Compositions, gels and foams with rheology modulators and uses thereof23 Jun 2026US 12,661,407 B2Journey Medical Corporation
- Systems and methods for transderman patch delivery8 Oct 2026US 2026/0306421 A1
- Topical composition8 Oct 2026US 2026/0306512 A1Api Corporation
- Sleep formulation1 Oct 2026US 2026/0294816 A1NightWise, LLC
- Beta-hydroxybutyrate for the dietary management of depression1 Oct 2026US 2026/0294854 A1Laureate Institute For Brain Research
- Treatment of hypoparathyroidism using triphenyl calcilytic compounds1 Oct 2026US 2026/0294857 A1Calcilytix Therapeutics, Inc.
Most cited
By later US patents
- (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses1,031US 7,094,916 B2Wisconsin Alumni Research Foundation · 2006
- Method and composition for the topical treatment of diabetic neuropathy114US 6,555,573 B2The Quigley Corporation · 2003
- Pharmaceutical composition93US 6,753,013 B1Leo Pharmaceutical Products Ltd. A/S · 2004
- Compositions with modulating agents86US 8,795,693 B2Foamix Ltd. · 2014
- Compositions with modulating agents84US 9,101,662 B2Foamix Pharmaceuticals Ltd. · 2015